Couverture média
7
Couverture média
Titre Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média Street Insider Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média Market News Publishing Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média InvestorsObserver Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média Yahoo! Finance Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média Chase Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média Health Technology Net Pays/Territoire United States Date 9/11/23 Personnes Carman Anthony Giacomantonio Titre Sona Nanotech Inc.: Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Nom du média FinanzNachrichten.de Pays/Territoire Germany Date 9/11/23 Personnes Carman Anthony Giacomantonio